APOL1 and chronic kidney disease: Patients with high-risk APOL1 genotypes are not only more likely to develop CKD, but also more likely to progress to end-stage kidney disease (ESKD) (Foster et al., 2013; Fine et al., 2012; Kopp et al., 2011).